GSK-ROP112771

Study Sponsor: GSK

Study Title

An open label study conducted in healthy subjects to demonstrate bioequivalence between ropinirole prolonged release tablets (ropinirole XL, marketed as REQUIP-MODUTAB™, REQUIP XL™ at 2 mg) manufactured at Crawley and Aranda

Medicine or Vaccine (generic name)

ropinirole

Sponsor Identification Number

ROP112771

Trial Registry Identification Number(#'s)

NCT01371682 2009-013229-41

Medical Condition

Parkinson Disease

Phase

Phase 1

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=112771

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01371682

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2009-013229-41

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2013